Literature DB >> 12676171

Renin-angiotensin system in the carotid body.

Po Sing Leung1, Man Lung Fung, Michael S C Tam.   

Abstract

Research studies have been done on the influence of the renin-angiotensin system (RAS) on numerous tissues and organs. The local RAS, which is frequently of paracrine/autocrine origin, caters to specific organ and tissue needs through actions that add to, or differ from, the circulating RAS. Recent data have demonstrated a functional expression of RAS in the carotid body, wherein the carotid chemoreceptors play a major physiological role in the regulation of autonomic responses to changes in arterial chemical content. However, the angiotensin II and other vasoactive substances can directly modulate the excitability of the chemoreceptor. Long-term hypoxia modifies the level of gene expression in the carotid body by increasing the expression of AT(1) receptors along with sensitivity of the chemoreceptor to angiotensin II. Even though these findings support a physiological role of RAS in the carotid body, it has yet to be clearly defined. As a result this review will present current information about expression and localization of AT(1) receptors, and show that local RAS exists in the carotid body. The regulation of RAS by chronic hypoxia, the significance of its changes and clinical relevance in the carotid body, are also addressed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676171     DOI: 10.1016/s1357-2725(02)00180-2

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  11 in total

Review 1.  Peripheral chemoreceptors: function and plasticity of the carotid body.

Authors:  Prem Kumar; Nanduri R Prabhakar
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

2.  Comparative gene expression profile of mouse carotid body and adrenal medulla under physiological hypoxia.

Authors:  M D Ganfornina; M T Pérez-García; G Gutiérrez; E Miguel-Velado; J R López-López; A Marín; D Sánchez; C González
Journal:  J Physiol       Date:  2005-05-12       Impact factor: 5.182

Review 3.  Angiotensin and carotid body chemoreception in heart failure.

Authors:  Harold D Schultz
Journal:  Curr Opin Pharmacol       Date:  2011-01-15       Impact factor: 5.547

Review 4.  The Role of Pharmacological Treatment in the Chemoreflex Modulation.

Authors:  Anna Langner-Hetmańczuk; Stanisław Tubek; Piotr Niewiński; Piotr Ponikowski
Journal:  Front Physiol       Date:  2022-06-14       Impact factor: 4.755

5.  Angiotensin II Type 1 Receptors and Systemic Hemodynamic and Renal Responses to Stress and Altered Blood Volume in Conscious Rabbits.

Authors:  Tony B Xu; Gabriela A Eppel; Geoffrey A Head; Roger G Evans
Journal:  Front Physiol       Date:  2011-07-19       Impact factor: 4.566

6.  Cancer, inflammation and the AT1 and AT2 receptors.

Authors:  Gary Robert Smith; Sotiris Missailidis
Journal:  J Inflamm (Lond)       Date:  2004-09-30       Impact factor: 4.981

Review 7.  Local RAS.

Authors:  Po Sing Leung
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 8.  Mechanisms of carotid body chemoreflex dysfunction during heart failure.

Authors:  Harold D Schultz; Noah J Marcus; Rodrigo Del Rio
Journal:  Exp Physiol       Date:  2015-01-15       Impact factor: 2.969

9.  Carotid Body AT(4) Receptor Expression and its Upregulation in Chronic Hypoxia.

Authors:  Man-Lung Fung; Siu-Yin Lam; Tung-Po Wong; Yung-Wui Tjong; Po-Sing Leung
Journal:  Open Cardiovasc Med J       Date:  2007-06-11

10.  The potential role of the carotid body in COVID-19.

Authors:  Andrea Porzionato; Aron Emmi; Elena Stocco; Silvia Barbon; Rafael Boscolo-Berto; Veronica Macchi; Raffaele De Caro
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-05       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.